Price Milestone and Market Context
From a 52-week low of Rs 6,680 to the new peak of Rs 8,491.15, Apollo Hospitals Enterprise Ltd. has delivered a robust 22.34% return over the past year, significantly outperforming the Sensex, which has declined by 10.49% in the same period. This rally is particularly notable given the Sensex’s recent struggles, trading 3.04% above its 52-week low and enduring a three-week consecutive fall, with the index currently below its 50-day moving average. Meanwhile, mega-cap stocks like Apollo Hospitals have been market leaders, helping to cushion broader market weakness. What factors are enabling this stock to buck the broader market downtrend and hit new highs?
Technical Indicators Paint a Bullish Picture
The technical landscape for Apollo Hospitals Enterprise Ltd. is overwhelmingly positive, with multiple indicators aligning to support the current uptrend. The stock is trading comfortably above all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — signalling strong price momentum across short, medium, and long-term horizons.
On the weekly timeframe, the Moving Average Convergence Divergence (MACD) indicator is bullish, confirming upward momentum, while the Bollinger Bands also suggest the stock is riding a strong upward volatility band. The Know Sure Thing (KST) oscillator on the weekly chart is bullish, although it shows mild bearishness on the monthly scale, hinting at some caution in the longer term. The Relative Strength Index (RSI) remains neutral on both weekly and monthly charts, indicating the stock is not yet overbought despite the recent gains.
Dow Theory readings present a mildly bearish signal on the weekly chart but show no clear trend on the monthly timeframe, suggesting that while short-term oscillations may occur, the broader trend remains intact. On-Balance Volume (OBV) does not show a definitive trend, implying volume has not yet decisively confirmed the price move but has not contradicted it either. How sustainable is this technical momentum given the mixed signals from some oscillators?
Key Data at a Glance
This week's revealed pick, a Large Cap from Public Banks with TARGET PRICE, is already showing movement! Get the complete analysis before it's too late.
- - Target price included
- - Early movement detected
- - Complete analysis ready
Quarterly Results Fuel Momentum
Apollo Hospitals Enterprise Ltd. has demonstrated consistent financial strength, reporting positive results for ten consecutive quarters. The latest quarter saw net sales reach a record ₹6,605.50 crores, with operating profit (PBDIT) hitting ₹1,011 crores, both all-time highs. This steady growth in top-line and operating profitability underpins the technical strength and investor confidence reflected in the stock’s price action.
Return on Capital Employed (ROCE) remains robust at 17.13%, indicating efficient capital utilisation. The company’s operating profit margin of 38.67% further highlights operational effectiveness. These fundamentals provide a solid backdrop for the technical rally, even as the broader market faces headwinds. Does the consistency in quarterly earnings growth fully justify the current price momentum?
Valuation and Data Points to Note
Despite the strong price performance, Apollo Hospitals trades at an attractive valuation relative to its peers, with an enterprise value to capital employed ratio of 8. The PEG ratio stands at 1.7, reflecting a balance between price appreciation and earnings growth, which has risen by 35.3% over the past year. This suggests that the stock’s price gains are supported by underlying profit expansion rather than speculative exuberance.
Institutional investors hold a significant 65.61% stake, signalling confidence from market participants with deep analytical resources. The company’s market capitalisation of ₹1,20,118 crores makes it the largest player in the hospital sector, accounting for nearly 20% of the industry’s market value. Its annual sales of ₹25,228.50 crores represent close to 28% of the sector’s total, underscoring its dominant position.
At a fresh 52-week high with strong earnings growth but moderate return ratios, should you buy, sell, or hold Apollo Hospitals Enterprise Ltd.? The detailed multi-parameter analysis has the answer.
Apollo Hospitals Enterprise Ltd. caught your attention? Explore our comprehensive research report with in-depth analysis of this large-cap Hospital stock – fundamentals, valuations, financials, and technical outlook!
- - Comprehensive research report
- - In-depth large-cap analysis
- - Valuation assessment included
Momentum in Focus
The current rally in Apollo Hospitals Enterprise Ltd. is underpinned by a broad-based technical advance, with the stock clearing all major moving averages and supported by bullish MACD and Bollinger Bands on weekly and monthly charts. While some indicators such as the KST and Dow Theory show mild caution, these are outweighed by the overall positive momentum and strong quarterly earnings growth.
Trading volume trends remain neutral, suggesting the move is steady rather than speculative. The stock’s outperformance relative to the sector and the broader market, especially during a period when the Sensex is under pressure, highlights its resilience. With the technical alignment so striking, is this momentum sustainable or nearing exhaustion?
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
